A Phase 2 Evaluation of Anti-VEGF Therapy for Diabetic Macular Edema: Bevacizumab (Avastin)
Public ClinicalTrials.gov record NCT00336323. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will provide preliminary data on the dose and dose interval related effects of intravitreally administered Avastin on retinal thickness and visual acuity in subjects with Diabetic Macular Edema (DME) to aid in planning a phase 3 trial. In addition, this study will provide preliminary data on the safety of intravitreally administered Avastin in subjects with DME.
Study identification
- NCT ID
- NCT00336323
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 121 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2006 (Type not available)
- Primary completion
- Nov 2006 (Actual)
- Completion
- Feb 2008 (Actual)
- Last update posted
- Aug 26, 2016
2006 – 2008
United States locations
- U.S. sites
- 34
- U.S. states
- 19
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Loma Linda University Health Care, Dept. of Ophthalmology | Loma Linda | California | 92354 | — |
| Southern California Desert Retina Consultants, MC | Palm Springs | California | 92262 | — |
| California Retina Consultants | Santa Barbara | California | 93103 | — |
| Bay Area Retina Associates | Walnut Creek | California | 94598 | — |
| Retina Vitreous Consultants | Fort Lauderdale | Florida | 33334 | — |
| Central Florida Retina Institute | Lakeland | Florida | 33805 | — |
| Southeast Retina Center, P.C. | Augusta | Georgia | 30909 | — |
| Illinois Retina Associates | Joliet | Illinois | 60435 | — |
| Raj K. Maturi, M.D., P.C. | Indianapolis | Indiana | 46280 | — |
| American Eye Institute | New Albany | Indiana | 47150 | — |
| Retina and Vitreous Associates of Kentucky | Lexington | Kentucky | — | — |
| Paducah Retinal Center | Paducah | Kentucky | 42001 | — |
| Maine Vitreoretinal Consultants | Bangor | Maine | 04401 | — |
| Elman Retina Group, P.A. | Baltimore | Maryland | 21237 | — |
| Retina Consultants of Delmarva, P.A. | Salisbury | Maryland | 21801 | — |
| Ophthalmic Consultants of Boston | Boston | Massachusetts | 02114 | — |
| Joslin Diabetes Center | Boston | Massachusetts | 02215 | — |
| Retina Center, PA | Minneapolis | Minnesota | 55404 | — |
| Charlotte Eye, Ear, Nose and Throat Assoc., PA | Charlotte | North Carolina | 28210 | — |
| Wake Forest University Eye Center | Winston-Salem | North Carolina | 27157 | — |
| Retina Associates of Cleveland, Inc. | Beachwood | Ohio | 44122 | — |
| Retina Northwest, PC | Portland | Oregon | 97210 | — |
| Casey Eye Institute | Portland | Oregon | 97239 | — |
| Penn State College of Medicine | Hershey | Pennsylvania | 17033 | — |
| Retina Consultants | Providence | Rhode Island | 02903 | — |
| Palmetto Retina Center | Columbia | South Carolina | 29169 | — |
| Carolina Retina Center | Columbia | South Carolina | 29223 | — |
| Southeastern Retina Associates, P.C. | Knoxville | Tennessee | 37909 | — |
| West Texas Retina Consultants P.A. | Abilene | Texas | 79605 | — |
| Retina Research Center | Austin | Texas | 78705 | — |
| Texas Retina Associates | Dallas | Texas | 75231 | — |
| Charles A. Garcia, PA & Associates | Houston | Texas | 77002 | — |
| Texas Retina Associates | Lubbock | Texas | 79424 | — |
| University of Washington Medical Center | Seattle | Washington | 98195 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00336323, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 26, 2016 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00336323 live on ClinicalTrials.gov.